EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Red blood cell membrane proteome as a reporter of disease severity, transfusion impact and genetic background in transfusion‐dependent β‐thalassaemia

Konstantina Theocharaki, Sophia Delicou iD, Aikaterini Ntzoura-Kani, Nikolaos Simantiris, Marianna Politou, Veroniki Komninaka, Martina Samiotaki, Jerome Zoidakis, Marianna H Antonelou

British Journal of Haematology · 2026-06 · 208 (6) · 1980-1992

DOI: 10.1111/bjh.70462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 09.04.2026. Verfasst von Konstantina Theocharaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, School of Science, National and Kapodistrian University of Athens (NKUA), Athens, Greece. Hauptthemen laut MEDLINE: beta-Thalassemia, Erythrocyte Membrane, Proteome. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HEAL-Link, Hellenic Academic Libraries Link.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Omics technologies have transformed research in haemoglobinopathies, yet the proteome of RBCs remains largely unexplored in transfusion‐dependent thalassaemia (TDT). In this proteomic analysis, Red blood cell (RBC) membranes from 48 adults with TDT were compared with healthy controls. The resulting profile, corresponding to patient and donor RBCs, captured disease‐linked features and exposure to donor blood. Certain differentially expressed proteins were plasma‐absorbed or remnants of erythroid precursors, recapitulating findings in non‐transfusion‐dependent thalassaemia. Structural proteins were overexpressed en bloc, especially in severe haemoglobin subunit beta ( HBB ) mutations, though higher transfusion doses attenuate these abnormalities. Other changes suggested impaired volume regulation, increased RBC adhesion and features not included in storage lesions, like downregulation of galectin‐3 and septins (identified in TDT for the first time), which were modulated by genetic‐ and transfusion‐related variables. JAM‐A, an endothelium inflammation marker, was significantly related to heart T2*. Splenectomy correlated with oxidative, coagulative and inflammatory patterns. The moderate and severe genotype groups had similar proteomic and cell morphology profiles compared to the mildest cases. Upregulation of ferroportin, ICAM4, eryptosis and circadian rhythm‐related proteins further characterized severe HBB genotypes. Transfusion dose effects varied across clinical groups. Overall, the RBC membrane emerges as both a target and a sensitive reporter of the complex pathophysiology underlying TDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaErythrocyte MembraneProteomeHumansFemaleAdultMaleProteomicsMiddle AgedSeverity of Illness IndexYoung AdultBlood Transfusion

Stichwörter der Autor:innen

HBB mutations severityRBC membrane proteomicsRBC storage lesionsplenectomytransfusion dosetransfusion‐dependent thalassaemia

Substanzen

Proteome

Autor:innen und Institutionen

  • Department of Biology, School of Science, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
  • Thalassemia and Sickle Cell Unit, Expertise Center of Hemoglobinopathies and Their Complications, Hippokration General Hospital, Athens, Greece.
  • Department of Environment, Faculty of Environment, Ionian University, Kerkira, Greece.
  • Hematology Laboratory-Blood Bank, Aretaieio Hospital, School of Medicine, NKUA, Athens, Greece.
  • Laboratory of Hematology, Gennimatas General Hospital, Athens, Greece.
  • Institute for Bio-Innovation, Biomedical Sciences Research Center "Alexander Fleming", Vari, Greece.

ORCID-Profile: Sophia Delicou

Förderung

  • HEAL-Link
  • Hellenic Academic Libraries Link

Zitieren

APA

Theocharaki, K., Delicou, S., Ntzoura-Kani, A., Simantiris, N., Politou, M., Komninaka, V., Samiotaki, M., Zoidakis, J., & Antonelou, M. H. (2026). Red blood cell membrane proteome as a reporter of disease severity, transfusion impact and genetic background in transfusion‐dependent β‐thalassaemia. British Journal of Haematology, 208(6), 1980-1992. https://doi.org/10.1111/bjh.70462

Vancouver

Theocharaki K, Delicou S, Ntzoura-Kani A, Simantiris N, Politou M, Komninaka V, et al. Red blood cell membrane proteome as a reporter of disease severity, transfusion impact and genetic background in transfusion‐dependent β‐thalassaemia. British Journal of Haematology. 2026;208(6):1980-1992. doi:10.1111/bjh.70462

BibTeX
@article{Theocharaki2026,
  author = {Theocharaki, Konstantina and Delicou, Sophia and Ntzoura-Kani, Aikaterini and Simantiris, Nikolaos and Politou, Marianna and Komninaka, Veroniki and Samiotaki, Martina and Zoidakis, Jerome and Antonelou, Marianna H},
  title = {Red blood cell membrane proteome as a reporter of disease severity, transfusion impact and genetic background in transfusion‐dependent β‐thalassaemia},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {208},
  number = {6},
  pages = {1980--1992},
  doi = {10.1111/bjh.70462}
}
Kostenlos starten →